$SRRK
Scholar Rock Holding Corporation Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Scholar Rock Holding Corporation Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is SRRK up today? It is at $50.27 (+4.57%), and our scanner flagged it 152 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SRRK spikes, and full due diligence on SRRK — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SRRK 152 times in the last 30 days. Create a free account to track $SRRK, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SRRK from our scanner (live price and day move above). Our scanner has fired 13 unusual-volume and momentum alerts on SRRK today, peaking at 13.3x its normal volume.
Likely catalystScholar Rock Holding Corp: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 16, 2026 · 3 days agoThe company can keep selling new shares into the market. Size not stated in the filing.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
4,362,050 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $200.0M in size · Priced at $45.85/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Akkaraju Srinivas Director | Bought (open market) | +147K 0.1% of company | added 2.1% | 7.10M | $6.1M at $41.59 | Oct 26, 26 |
Akkaraju Srinivas Director | Bought (open market) | +143K 0.1% of company | added 2.3% | 6.33M | $5.9M at $41.31 | Oct 23, 26 |
Woods Keith Officer | Sold (automatic/other) | -48K 0.04% of company | sold 7.7% | 572K | n/a | Sep 24, 26 |
Hallal David Officer | Sold (automatic/other) | -37K 0.03% of company | sold 2.2% | 1.60M | n/a | Sep 21, 26 |
Peng Katie Director | Sold (automatic/other) | -5K | sold 14% | 34K | $292K at $53.56 | Jul 1, 26 |
Reed Joshua Director | Sold (automatic/other) | -3K | sold 14% | 20K | $163K at $53.50 | Jul 1, 26 |
Burow Kristina Director | Sold (automatic/other) | -3K | sold 2.6% | 115K | $163K at $53.49 | Jul 1, 26 |
Flier Jeffrey S. Director | Sold (automatic/other) | -3K | sold 9.9% | 28K | $163K at $53.53 | Jul 1, 26 |
Gilman Michael Director | Sold (automatic/other) | -3K | sold 4.1% | 60K | $136K at $53.54 | Jul 1, 26 |
Akkaraju Srinivas Director | Acquired (grant/award) | +7K | added 32% | 28K | n/a | Jun 4, 26 |
Peng Katie Director | Acquired (grant/award) | +7K | added 21% | 40K | n/a | Jun 4, 26 |
Gilman Michael Director | Acquired (grant/award) | +7K | added 12% | 62K | n/a | Jun 4, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.



The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on SRRK from our scanner (live price and day move above). Our scanner has fired 13 unusual-volume and momentum alerts on SRRK today, peaking at 13.3x its normal volume.
SRRK last traded at $50.27, up 4.57% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The SRRK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SRRK 152 times in the last 30 days.
SRRK (Scholar Rock Holding Corporation Common Stock) trades on XNAS, with a market cap of about $5.86B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SRRK for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
Our ShortTop 5 stocks insiders are buyingWatch on YouTube · Nov 4
$SRRK discussion
Sign in to ask a question or join the discussion.